Is Microsoft an Undervalued Growth Stock to Buy?
Tech giant Microsoft (NASDAQ:MSFT) has been one of the biggest…
Sell
16
THQ Quote, Financials, Valuation and Earnings
Last price:
$19.28
Seasonality move
:
-2.69%
Day range:
$19.17 - $19.40
52-week range:
$17.92 - $22.60
Dividend yield:
10.5%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
125.6K
Avg. volume:
188.7K
1-year change:
5.64%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
THQ
Tekla Healthcare Opportunities Fund
|
$19.29 | -- | -- | -- | $0.36 | 10.5% | -- |
|
BME
Blackrock Health Sciences Trust
|
$38.32 | -- | -- | -- | $0.26 | 0.33% | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
$14.66 | -- | -- | -- | $0.18 | 1.21% | -- |
|
HQH
abrdn Healthcare Investors
|
$16.46 | -- | -- | -- | $0.62 | 0% | -- |
|
PPH
VanEck Pharmaceutical ETF
|
$87.17 | -- | -- | -- | $0.41 | 1.96% | -- |
|
THW
Tekla World Healthcare Fund
|
$11.37 | -- | -- | -- | $0.12 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | 0.976 | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | 0.916 | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | 1.543 | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | 1.083 | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.750 | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | 0.694 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
Tekla Healthcare Opportunities Fund vs. Competitors
-
Which has Higher Returns THQ or BME?
Blackrock Health Sciences Trust has a net margin of -- compared to Tekla Healthcare Opportunities Fund's net margin of --. Tekla Healthcare Opportunities Fund's return on equity of -- beat Blackrock Health Sciences Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THQTekla Healthcare Opportunities Fund-- -- -- BMEBlackrock Health Sciences Trust-- -- -- -
What do Analysts Say About THQ or BME?
Tekla Healthcare Opportunities Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand Blackrock Health Sciences Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that Tekla Healthcare Opportunities Fund has higher upside potential than Blackrock Health Sciences Trust, analysts believe Tekla Healthcare Opportunities Fund is more attractive than Blackrock Health Sciences Trust.
Company Buy Ratings Hold Ratings Sell Ratings THQTekla Healthcare Opportunities Fund0 0 0 BMEBlackrock Health Sciences Trust0 0 0 -
Is THQ or BME More Risky?
Tekla Healthcare Opportunities Fund has a beta of 0.935, which suggesting that the stock is 6.506% less volatile than S&P 500. In comparison Blackrock Health Sciences Trust has a beta of 0.680, suggesting its less volatile than the S&P 500 by 32.048%.
-
Which is a Better Dividend Stock THQ or BME?
Tekla Healthcare Opportunities Fund has a quarterly dividend of $0.36 per share corresponding to a yield of 10.5%. Blackrock Health Sciences Trust offers a yield of 0.33% to investors and pays a quarterly dividend of $0.26 per share. Tekla Healthcare Opportunities Fund pays -- of its earnings as a dividend. Blackrock Health Sciences Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THQ or BME?
Tekla Healthcare Opportunities Fund quarterly revenues are --, which are smaller than Blackrock Health Sciences Trust quarterly revenues of --. Tekla Healthcare Opportunities Fund's net income of -- is lower than Blackrock Health Sciences Trust's net income of --. Notably, Tekla Healthcare Opportunities Fund's price-to-earnings ratio is -- while Blackrock Health Sciences Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tekla Healthcare Opportunities Fund is -- versus -- for Blackrock Health Sciences Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THQTekla Healthcare Opportunities Fund-- -- -- -- BMEBlackrock Health Sciences Trust-- -- -- --
-
Which has Higher Returns THQ or BMEZ?
BlackRock Health Sciences Trust II has a net margin of -- compared to Tekla Healthcare Opportunities Fund's net margin of --. Tekla Healthcare Opportunities Fund's return on equity of -- beat BlackRock Health Sciences Trust II's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THQTekla Healthcare Opportunities Fund-- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- -
What do Analysts Say About THQ or BMEZ?
Tekla Healthcare Opportunities Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Health Sciences Trust II has an analysts' consensus of -- which suggests that it could fall by --. Given that Tekla Healthcare Opportunities Fund has higher upside potential than BlackRock Health Sciences Trust II, analysts believe Tekla Healthcare Opportunities Fund is more attractive than BlackRock Health Sciences Trust II.
Company Buy Ratings Hold Ratings Sell Ratings THQTekla Healthcare Opportunities Fund0 0 0 BMEZBlackRock Health Sciences Trust II0 0 0 -
Is THQ or BMEZ More Risky?
Tekla Healthcare Opportunities Fund has a beta of 0.935, which suggesting that the stock is 6.506% less volatile than S&P 500. In comparison BlackRock Health Sciences Trust II has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock THQ or BMEZ?
Tekla Healthcare Opportunities Fund has a quarterly dividend of $0.36 per share corresponding to a yield of 10.5%. BlackRock Health Sciences Trust II offers a yield of 1.21% to investors and pays a quarterly dividend of $0.18 per share. Tekla Healthcare Opportunities Fund pays -- of its earnings as a dividend. BlackRock Health Sciences Trust II pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THQ or BMEZ?
Tekla Healthcare Opportunities Fund quarterly revenues are --, which are smaller than BlackRock Health Sciences Trust II quarterly revenues of --. Tekla Healthcare Opportunities Fund's net income of -- is lower than BlackRock Health Sciences Trust II's net income of --. Notably, Tekla Healthcare Opportunities Fund's price-to-earnings ratio is -- while BlackRock Health Sciences Trust II's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tekla Healthcare Opportunities Fund is -- versus -- for BlackRock Health Sciences Trust II. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THQTekla Healthcare Opportunities Fund-- -- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- --
-
Which has Higher Returns THQ or HQH?
abrdn Healthcare Investors has a net margin of -- compared to Tekla Healthcare Opportunities Fund's net margin of --. Tekla Healthcare Opportunities Fund's return on equity of -- beat abrdn Healthcare Investors's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THQTekla Healthcare Opportunities Fund-- -- -- HQHabrdn Healthcare Investors-- -- -- -
What do Analysts Say About THQ or HQH?
Tekla Healthcare Opportunities Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Investors has an analysts' consensus of -- which suggests that it could fall by --. Given that Tekla Healthcare Opportunities Fund has higher upside potential than abrdn Healthcare Investors, analysts believe Tekla Healthcare Opportunities Fund is more attractive than abrdn Healthcare Investors.
Company Buy Ratings Hold Ratings Sell Ratings THQTekla Healthcare Opportunities Fund0 0 0 HQHabrdn Healthcare Investors0 0 0 -
Is THQ or HQH More Risky?
Tekla Healthcare Opportunities Fund has a beta of 0.935, which suggesting that the stock is 6.506% less volatile than S&P 500. In comparison abrdn Healthcare Investors has a beta of 0.769, suggesting its less volatile than the S&P 500 by 23.068%.
-
Which is a Better Dividend Stock THQ or HQH?
Tekla Healthcare Opportunities Fund has a quarterly dividend of $0.36 per share corresponding to a yield of 10.5%. abrdn Healthcare Investors offers a yield of 0% to investors and pays a quarterly dividend of $0.62 per share. Tekla Healthcare Opportunities Fund pays -- of its earnings as a dividend. abrdn Healthcare Investors pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THQ or HQH?
Tekla Healthcare Opportunities Fund quarterly revenues are --, which are smaller than abrdn Healthcare Investors quarterly revenues of --. Tekla Healthcare Opportunities Fund's net income of -- is lower than abrdn Healthcare Investors's net income of --. Notably, Tekla Healthcare Opportunities Fund's price-to-earnings ratio is -- while abrdn Healthcare Investors's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tekla Healthcare Opportunities Fund is -- versus -- for abrdn Healthcare Investors. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THQTekla Healthcare Opportunities Fund-- -- -- -- HQHabrdn Healthcare Investors-- -- -- --
-
Which has Higher Returns THQ or PPH?
VanEck Pharmaceutical ETF has a net margin of -- compared to Tekla Healthcare Opportunities Fund's net margin of --. Tekla Healthcare Opportunities Fund's return on equity of -- beat VanEck Pharmaceutical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THQTekla Healthcare Opportunities Fund-- -- -- PPHVanEck Pharmaceutical ETF-- -- -- -
What do Analysts Say About THQ or PPH?
Tekla Healthcare Opportunities Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Pharmaceutical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tekla Healthcare Opportunities Fund has higher upside potential than VanEck Pharmaceutical ETF, analysts believe Tekla Healthcare Opportunities Fund is more attractive than VanEck Pharmaceutical ETF.
Company Buy Ratings Hold Ratings Sell Ratings THQTekla Healthcare Opportunities Fund0 0 0 PPHVanEck Pharmaceutical ETF0 0 0 -
Is THQ or PPH More Risky?
Tekla Healthcare Opportunities Fund has a beta of 0.935, which suggesting that the stock is 6.506% less volatile than S&P 500. In comparison VanEck Pharmaceutical ETF has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.432%.
-
Which is a Better Dividend Stock THQ or PPH?
Tekla Healthcare Opportunities Fund has a quarterly dividend of $0.36 per share corresponding to a yield of 10.5%. VanEck Pharmaceutical ETF offers a yield of 1.96% to investors and pays a quarterly dividend of $0.41 per share. Tekla Healthcare Opportunities Fund pays -- of its earnings as a dividend. VanEck Pharmaceutical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THQ or PPH?
Tekla Healthcare Opportunities Fund quarterly revenues are --, which are smaller than VanEck Pharmaceutical ETF quarterly revenues of --. Tekla Healthcare Opportunities Fund's net income of -- is lower than VanEck Pharmaceutical ETF's net income of --. Notably, Tekla Healthcare Opportunities Fund's price-to-earnings ratio is -- while VanEck Pharmaceutical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tekla Healthcare Opportunities Fund is -- versus -- for VanEck Pharmaceutical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THQTekla Healthcare Opportunities Fund-- -- -- -- PPHVanEck Pharmaceutical ETF-- -- -- --
-
Which has Higher Returns THQ or THW?
Tekla World Healthcare Fund has a net margin of -- compared to Tekla Healthcare Opportunities Fund's net margin of --. Tekla Healthcare Opportunities Fund's return on equity of -- beat Tekla World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THQTekla Healthcare Opportunities Fund-- -- -- THWTekla World Healthcare Fund-- -- -- -
What do Analysts Say About THQ or THW?
Tekla Healthcare Opportunities Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Tekla Healthcare Opportunities Fund has higher upside potential than Tekla World Healthcare Fund, analysts believe Tekla Healthcare Opportunities Fund is more attractive than Tekla World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings THQTekla Healthcare Opportunities Fund0 0 0 THWTekla World Healthcare Fund0 0 0 -
Is THQ or THW More Risky?
Tekla Healthcare Opportunities Fund has a beta of 0.935, which suggesting that the stock is 6.506% less volatile than S&P 500. In comparison Tekla World Healthcare Fund has a beta of 0.927, suggesting its less volatile than the S&P 500 by 7.302%.
-
Which is a Better Dividend Stock THQ or THW?
Tekla Healthcare Opportunities Fund has a quarterly dividend of $0.36 per share corresponding to a yield of 10.5%. Tekla World Healthcare Fund offers a yield of 0% to investors and pays a quarterly dividend of $0.12 per share. Tekla Healthcare Opportunities Fund pays -- of its earnings as a dividend. Tekla World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THQ or THW?
Tekla Healthcare Opportunities Fund quarterly revenues are --, which are smaller than Tekla World Healthcare Fund quarterly revenues of --. Tekla Healthcare Opportunities Fund's net income of -- is lower than Tekla World Healthcare Fund's net income of --. Notably, Tekla Healthcare Opportunities Fund's price-to-earnings ratio is -- while Tekla World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tekla Healthcare Opportunities Fund is -- versus -- for Tekla World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THQTekla Healthcare Opportunities Fund-- -- -- -- THWTekla World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
